Roivant Sciences Ltd.
$21.35B- Market cap
- $25.23B
- Debt
- +$412.94M
- Cash
- −$4.29B
Capital structure 98% equity / 2% debt · EV / Revenue 2584.97x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ROIV · current priceP/S 3054.57x
$34.93Latest market snapshot
Implied fair value · at RES's multiple
$0.01100.0% below market
0.01 ROIV revenue / share×0.89x RES P/S=$0.01
Market $34.93Implied $0.01
RES · current priceP/S 0.89x
$6.50Latest market snapshot
Implied fair value · at ROIV's multiple
$22,415.08344,747.3% above market
7.34 RES revenue / share×3054.57x ROIV P/S=$22,415.08
Market $6.50Implied $22,415.08